The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism

Inclusion Criteria for type II diabetes: Women and men, 18-75 years old Patients diagnosed with type II diabetes mellitus Patients on metformin treatment up to 5 months BMI 20-35 kg/m2 Signed informed consent Inclusion Criteria for prediabetes: Women and men, 18-75 years old BMI 20-35 kg/m2 Fasting blood glucose levels between 100 mg/dl and 125 mg/dl (5.6-6.9 mmol/l) Signed informed consent Exclusion Criteria for type II diabetes: Patients diagnosed with type I diabetes Patients receiving insulin or other anti-diabetic medications Women who are pregnant, planning to become pregnant during the study, or breastfeeding Surgery within the last 6 months Intake of dietary supplements containing plant extracts rich in polyphenols and anthocyanins Intake of supplements containing: white mulberry, chromium, berberine Patients receiving glucocorticosteroids, immunosuppressants Oncological disease, autoimmune disease, severe liver dysfunction, tuberculosis, leukemia, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplant Acute inflammation (C-reactive protein >20mg/dl) Exclusion Criteria for prediabetes: Patients diagnosed with type I, II, LADA diabetes Patients receiving insulin or other anti-diabetic medications Women who are pregnant, planning to become pregnant during the study, or breastfeeding Surgery within the last 6 months Intake of dietary supplements containing plant extracts rich in polyphenols and anthocyanins Intake of supplements containing: white mulberry, chromium, berberine Patients receiving glucocorticosteroids, immunosuppressants Oncological disease, autoimmune disease, severe liver dysfunction, tuberculosis, leukemia, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplant Acute inflammation (C-reactive protein >20mg/dl)